{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-001516","form_type":"8-K","ticker":"PTIX","cik":"0001022899","company_name":"Protagenic Therapeutics, Inc.new","filed_at":"2025-01-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.724189+00:00","generated_at":"2026-05-28T04:24:39.300086+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Protagenic Therapeutics enters ATM sales agreement for up to $1.2M with B. Riley Securities","bullets":["Amendment No. 1 to At Market Issuance Sales Agreement with B. Riley Securities, dated Jan 9, 2025.","Company may sell up to $1.2 million of common stock from time to time in at-the-market offerings.","Agent commission is 3.0% of gross sales price; Company can terminate agreement on notice.","Sales will be made under effective shelf registration statement (333-280244), declared effective Jan 8, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-001516","json":"https://secwatch.observer/filing/0001493152-25-001516.json","markdown":"https://secwatch.observer/filing/0001493152-25-001516.md","text":"https://secwatch.observer/filing/0001493152-25-001516.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1022899/000149315225001516/0001493152-25-001516-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1022899/000149315225001516/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-28T04:24:39.300086+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}